Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2025-12-24 @ 4:57 PM
NCT ID: NCT05872750
Eligibility Criteria: Inclusion Criteria: 1. age between 18 and 65 years; 2. fulfilling at least 4 of the Diagnostic and Statistical Manual version 5 (DSM-5) criteria of gambling disorder for at least 12-month assessed by the Structured Clinical Interview Exclusion Criteria: 1. Inability to provide informed consent or comprehend the study procedure; 2. A major psychiatric illness that required chronic psychotropic medication or inpatient treatment, including schizophrenia spectrum disorder, bipolar spectrum disorder, and major depressive disorder with psychotic features. 3. A current DSM-5 diagnosis of substance use disorder except nicotine use disorder or the use of one to two low-potency benzodiazepine tablets for sleep impairment; 4. Have known preexisting noise-induced hearing loss, concurrent treatment with ototoxic medications, or with cochlear implants. 5. Unstable medical illness, including malignancy, uncontrolled diabetes mellitus, unstable cardiac disease or recent myocardial infarction, or cerebrovascular or cardiovascular risk factors that require intensive medical management 6. On medications known to lower seizure threshold (e.g., TCA, bupropion, clozapine) 7. Implants controlled by physiological signals, including pacemaker, implantable cardioverter defibrillator, cochlear implant. 8. Metallic objects in the head, including stenting, suture. 9. Elevated risk of seizure due to traumatic brain history, seizure history, and head trauma, intracranial lesion, and alcohol or benzodiazepines withdrawal syndrome, stimulant intoxication.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT05872750
Study Brief:
Protocol Section: NCT05872750